Xiangwei Xu

10PUBLICATIONS
9CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsTraditional Chinese medicine and treatmentsWater treatment processesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 08, 2026
Discovery of Novel AURKA Inhibitors for Triple-Negative Breast Cancer (TNBC) Therapy via a Hybrid Virtual Screening Pipeline, Biological Evaluation and Molecular Dynamics Simulation.

|Feb 12, 2026
Discovery of Novel HPK1 Inhibitors via High-Throughput Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation.

Xinglong Chi, Yiqun Chu, Roufen Chen

|Nov 30, 2025
Banxia Xiexin Decoction Ameliorates Ulcerative Colitis via a Flora-Metabolite-Inflammation Axis Through Integrated Metabolomic and Microbiome Analysis.

Feng Ying, Wentao Shao, Long Li

|Oct 06, 2025
Taxifolin Attenuates Cisplatin-Induced Acute Kidney Injury by Promoting Fatty Acid Oxidation.

Xuejin Jin, Lingkun Wang, Miao Yuan

|Jan 21, 2025
Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of TiaoShenGongJian for the Treatment of Breast Cancer.

Huiyan Ying, Weikaixin Kong, Xiangwei Xu

|Sep 18, 2024
Virtual Screening and Molecular Docking: Discovering Novel METTL3 Inhibitors.

Junyi Yang, Yanwen He, Youkun Kang

Pageof 2

Frequent Collaborators

2 joint publications

Wenhai Huang

1 joint publications

Ji Ma

1 joint publications

Xia Zhao

1 joint publications

Yanwen He